Navegar

Colección

Datos Estadísticas

Lista de

carcinogenesis
49
"Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice" (2019) Zubeldía-Brenner, L.;De Winne, C.;Perrone, S. (...)Becu-Villalobos, D. Endocrine-Related Cancer. 26(1):13-29
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Programmed cell senescence: Role of IL-6 in the pituitary" (2017) Sapochnik, M.; Fuertes, M.; Arzt, E. Journal of Molecular Endocrinology. 58(4):R241-R253
"Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis" (2017) Méndez-Huergo, S.P.; Blidner, A.G.; Rabinovich, G.A. Current Opinion in Immunology. 45:8-15
"Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer" (2017) Gentilini, L.D.;Jaworski, F.M.;Tiraboschi, C. (...)Compagno, D. Oncotarget. 8(27):44654-44668
"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808
"Turning-off signaling by siglecs, selectins, and galectins: Chemical inhibition of glycan-dependent interactions in cancer" (2016) Cagnoni, A.J.; Pérez Sáez, J.M.; Rabinovich, G.A.; Mariño, K.V. Frontiers in Oncology. 6(MAY)
"Molecular Mechanisms Underlying Pituitary Pathogenesis" (2016) Sapochnik, M.; Nieto, L.E.; Fuertes, M.; Arzt, E. Biochemical Genetics. 54(2):107-119
"Role of RSUME in inflammation and cancer" (2015) Antico Arciuch, V.G.; Tedesco, L.; Fuertes, M.; Arzt, E. FEBS Letters. 589(22):3330-3335
"Galectins: Major signaling modulators inside and outside the cell" (2014) Compagno, D.;Jaworski, F.M.;Gentilini, L. (...)Laderach, D.J. Current Molecular Medicine. 14(5):630-651
"Galectins: Major signaling modulators inside and outside the cell" (2014) Compagno, D.;Jaworski, F.M.;Gentilini, L. (...)Laderach, D.J. Current Molecular Medicine. 14(5):630-651
"P19INK4d is involved in the cellular senescence mechanism contributing to heterochromatin formation" (2014) Sonzogni, S.V.;Ogara, M.F.;Belluscio, L.M. (...)Cánepa, E.T. Biochimica et Biophysica Acta - General Subjects. 1840(7):2171-2183
"Galectin-8: A matricellular lectin with key roles in angiogenesis" (2014) Troncoso, M.F.;Ferragut, F.;Bacigalupo, M.L. (...)Elola, M.T. Glycobiology. 24(10):907-914
"Galectin-8: A matricellular lectin with key roles in angiogenesis" (2014) Troncoso, M.F.;Ferragut, F.;Bacigalupo, M.L. (...)Elola, M.T. Glycobiology. 24(10):907-914
"Coupling between transcription and alternative splicing" (2013) Schor, I.E.; Gómez Acuña, L.I.; Kornblihtt, A.R.; Wu J.Y. Cancer Treatment and Research:1-24
"Folding of a cyclin box: Linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor ab pocket domain" (2013) Chemes, L.B.; Noval, M.G.; Sánchez, I.E.; De Prat-Gay, G. Journal of Biological Chemistry. 288(26):18923-18938
"Metronidazole induced DNA damage in somatic cells of Drosophila melanogaster" (2013) Palermo, A.M.; Mudry, M.D. Current Drug Safety. 8(3):195-198
"Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" (2012) Croci, D.O.;Salatino, M.;Rubinstein, N. (...)Rabinovich, G.A. Journal of Experimental Medicine. 209(11):1985-2000
"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"Animal models for aberrations of gonadotropin action" (2011) Peltoketo, H.; Zhang, F.-P.; Rulli, S.B. Reviews in Endocrine and Metabolic Disorders. 12(4):245-258
"Pituitary tumors: Cell type-specific roles for BMP-4" (2010) Labeur, M.;Páez-Pereda, M.;Haedo, M. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 326(1-2):85-88
"c-Jun regulates phosphoinositide-dependent kinase 1 transcription: Implication for Akt and protein kinase C activities melanoma tumorigenesis" (2010) Lopez-Bergami, P.;Kim, H.;Dewing, A. (...)Ronai, Z. Journal of Biological Chemistry. 285(2):903-913
"Cytokines and genes in pituitary tumorigenesis: RSUME role in cell biology" (2010) Fuertes, M.;Gerez, J.;Haedo, M. (...)Arzt, E. Frontiers of Hormone Research. 38:1-6
"Emerging roles of ATF2 and the dynamic AP1 network in cancer" (2010) Lopez-Bergami, P.; Lau, E.; Ronai, Z. Nature Reviews Cancer. 10(1):65-76
"VEGF and CD31 association in pituitary adenomas" (2010) Cristina, C.;Perez-Millan, M.I.;Luque, G. (...)Becu-Villalobos, D. Endocrine Pathology. 21(3):154-160
"Differential gene expression in models of pituitary prolactin-producing tumoral cells" (2009) Giacomini, D.;Haedo, M.;Gerez, J. (...)Arzt, E. Hormone Research. 71(SUPPL2):88-94
"Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer" (2007) Sacca, P.;Meiss, R.;Casas, G. (...)Vazquez, E. British Journal of Cancer. 97(12):1683-1689
"Pituitary action of cytokines: Focus on BMP-4 and gp130 family" (2007) Giacomini, D.;Acuña, M.;Gerez, J. (...)Arzt, E. Neuroendocrinology. 85(2):94-100
"INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions" (2007) Cánepa, E.T.;Scassa, M.E.;Ceruti, J.M. (...)Ogara, M.F. IUBMB Life. 59(7):419-426
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor" (2006) Marinissen, M.J.;Tanos, T.;Bolós, M. (...)Cuadrado, A. Journal of Biological Chemistry. 281(16):11332-11346
"Multiple sites of tumorigenesis in transgenic mice overproducing hCG" (2005) Huhtaniemi, I.; Rulli, S.; Ahtiainen, P.; Poutanen, M. Molecular and Cellular Endocrinology. 234(1-2):117-126
"Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model" (2004) Graciarena, M.;Carbia-Nagashima, A.;Onofri, C. (...)Arzt, E. European Journal of Endocrinology. 151(5):595-604
"Integrating systemic information at the molecular level: Cross-talk between steroid receptors and cytokine signaling on different target cells" (2003) Refojo, D.;Liberman, A.C.;Giacomini, D. (...)Arzt, E. Annals of the New York Academy of Sciences. 992:196-204
"Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats" (2000) Piroli, G.G.;Torres, A.;Pietranera, L. (...)De Nicola, A.F. Neuroendocrinology. 72(2):80-90
"Mitochondrial and cytosolic rhodanese from liver of DAB-treated mice III. Inhibition kinetic studies" (1997) Vazquez, E.; Gazzaniga, S.; Polo, C.; Batlle, A. Cancer Biochemistry Biophysics. 15(4):285-293
"Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes" (1994) Chasseing, N.A.; Eugui, E.M.; Borda, E.S.; Rumi, L. Cancer Investigation. 12(4):390-394
"Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis" (1993) Del Batlle, C.A.M. Journal of Photochemistry and Photobiology, B: Biology. 20(1):5-22
"Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis" (1993) Del Batlle, C.A.M. Journal of Photochemistry and Photobiology, B: Biology. 20(1):5-22